Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on Mar 30, 2012 3:34pm
172 Views
Post# 19740557

RE: Bad news coming??

RE: Bad news coming??

I doubt there is bad news. We only see one active seller. Only one funds or large shareholder liquidate his position. You can have one good reason to buy, but many for selling....

 

If the issue is the cash, I highly doubt that a client like Octapharma that have an approve product on the market, or even a global pharma in phase III that already spent hundreds of millions in clinical research, would ultimately let PLI go in bankruptcy. They depend on their technology, and they certainly can make a loan a few millions if it's ever needed. 

 

I will sleep thight tonight, no matter what will be the SP.

Bullboard Posts